source
- Biotech investors grow uneasy as XBI stalls despite overall gainsAdam Feuerstein notes that while biotech stocks have performed well overall this year, investor sentiment has turned sour after the summer. The SPDR S&P Biotech ETF (XBI) remains up about 24% year…
- DOJ ramps up health-care fraud investigations, urges companies to self-report and reward remediationAt the STAT Summit in Boston, DOJ officials announced a renewed focus on health-care fraud, especially targeting Medicare and Medicaid schemes. Deputy Assistant Attorney General Jacob Foster said…